![]() |
|
|
Vol. 292, Issue 1, 201-208, January 2000
University of Michigan Medical School, Department of Pharmacology,
Ann Arbor, Michigan (E.J.T., B.R.L.); and Kinsmen Laboratory of
Neurological Research, University of British Columbia, Vancouver,
British Columbia, Canada (K.Y., P.L.M.)
The exact mechanism of the cardiotoxic actions of cocaine remains
unclear. The finding that the heart may be a source of injurious complement components led us to investigate whether cocaine promotes myocardial expression of complement. Rabbit isolated hearts were perfused for 70 min with either cocaine hydrochloride (1 or 10 µM),
the synthetic isomer (+)-cocaine (10 µM), or procaine hydrochloride (10 or 30 µM). Compared with controls perfused with drug-free buffer,
both cocaine and procaine significantly (P < .05)
increased myocardial C1q, C1r, C8, and C9 mRNA expression, whereas 10 µM (+)-cocaine had no effect on complement mRNA expression. Cocaine also significantly increased (P < .05) C3 mRNA
transcription. In addition, in vivo administration of cocaine (1 mg/kg)
for three consecutive days significantly increased myocardial
complement mRNA expression. Cocaine and procaine also increased
membrane attack complex (MAC) formation in the myocardium. The
antioxidant 2-N-mercaptopropionyl glycine, attenuated
the increases in complement mRNA expression induced by 1 µM cocaine
and 10 µM procaine. In vivo heparin administration (300 U/kg i.v.),
2 h before removal of the heart and exposure to 1 µM cocaine,
did not inhibit C1q, C1r, C3, and C8 mRNA transcription, but decreased
MAC expression. It was determined previously that heparin reduces
myocardial ischemia/reperfusion injury. Our results suggest that
cocaine may cause myocardial injury by up-regulating local complement
expression, possibly via the production of reactive oxygen species.
Furthermore, the glycosaminoglycan heparin may modulate the cytotoxic
effects of cocaine by impeding formation of the MAC.
This article has been cited by other articles:
![]() |
S. Barik The Thrill Can Kill: Murder by Methylation Mol. Pharmacol., May 1, 2007; 71(5): 1203 - 1205. [Abstract] [Full Text] [PDF] |
||||